< Back to the list of products
Duvaxyn EHV1,4 - suspension for injection for horses
Carbopol adjuvanted inactivated whole virus vaccine containing EHV-1 and EHV-4 strains. To reduce clinical signs due to EHV-1,4 respiratory disease and reduce abortion caused by EHV-1 infection.
Description
Each dose of 1.5 ml contains:
| Active substances: | |
|---|---|
| Inactivated EHV1, strain 438/77 | not less than 107.3 TCID50 |
| Inactivated EHV4, strain 405/76 | not less than 107.3 TCID50 |
| Adjuvant: | |
| Carbopol 934P | 6 mg |
INDICATIONS
For active immunisation of horses to reduce clinical signs due to infection with Equine Herpes virus 1 and 4 and to reduce abortion caused by EHV-1 infection.
CONTRAINDICATIONS
Do not vaccinate unhealthy horses.
ADVERSE REACTIONS
In cases of local reaction, swellings usually measure not more than 5 cm diameter and disappear within 7 days post vaccination.
TARGET SPECIES
Horses
DOSAGE, ROUTE AND METHOD OF ADMINISTRATION
One dose per horse to be administered by deep intramuscular injection.
Primary course: A single dose should be administered from 5 months of age followed by a second injection after an interval of 4 to 6 weeks.
In the event of increased infection risk, for example when a foal had consumed insufficient colostrum or there is a risk of early exposure
to field infections with EHV-1 or EHV-4, earlier vaccination may be given. In these circumstances, the
foal should receive a single dose from 3 months of age followed by the above mentioned full primary vaccination course.
Booster: Following completion of the primary course, a single dose should be administered every 6 months.
Use in pregnant mares: To reduce abortion due to EHV-1 infection, pregnant mares should be vaccinated during the 5th,
7th and 9th month of pregnancy with a single 1.5 ml dose on each occasion.
WITHDRAWAL PERIOD
Zero days.
SHELF LIFE
Shelf life of the veterinary product as packaged for sale: 14 - 36 months. (May vary by country)
SPECIAL STORAGE PRECAUTIONS
The vaccine has to be stored and transported in its original unopened undamaged packing in the dark at +2°C - +8°C.
Exposure to heat and/or direct sunlight has to be avoided.
Do not freeze.
SPECIAL WARNINGS
Syringes and needles should not have been sterilised chemically or be above ambient temperature. Do not use chemicals to disinfect or sterilise the skin.
Can be used during pregnancy.
No information is available on the compatibility of this vaccine with any other. Therefore the safety and efficacy of this product when used with any other
(either when used on the same day or at different times) has not been demonstrated.
Do not mix with any other medicinal product.
Any unused veterinary medicinal product or waste materials derived from such veterinary
medicinal product should be disposed of in accordance with local requirements.
OTHER INFORMATION
ATCv code: QI05 AA 05
Nature and composition of immediate packaging
Single-dose (1.5ml)
Container: Type 1 glass Ph.Eur
Closure: Chlorobutyl rubber stopper PH 21/50 (Ph.Eur.). Aluminium crimp cap.
Pack sizes: 2, 10 and 50 dose packs.
Not all pack sizes may be marketed.
National label conditions must be observed by country.
